Connection
David Raben to Bevacizumab
This is a "connection" page, showing publications David Raben has written about Bevacizumab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.028 |
|
|
|
-
Wozniak AJ, Moon J, Thomas CR, Kelly K, Mack PC, Gaspar LE, Raben D, Fitzgerald TJ, Pandya KJ, Gandara DR. A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533. Clin Lung Cancer. 2015 Sep; 16(5):340-7.
Score: 0.028